Atlas Trials

TWi Biotechnology, Inc.

11 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch TWi Biotechnology, Inc.

RecordFirmDate
An International, Multicenter, Randomized, Double-Blind, Parallel Group, Vehicle-Controlled, Phase 2/3 Study With Open-Label Extension Evaluating the Efficacy and Safety of Diacerein 1% Ointment for the Treatment of Generalized Epidermolysis Bullosa Simplex (EBS) (NCT06073132)TWi Biotechnology, Inc.2024-04-04
A Study to Assess the Efficacy, Safety, and Tolerability of Oral NORA520 in Adults With Severe Postpartum Depression (NCT06285916)TWi Biotechnology, Inc.2024-03-28
Study to Evaluate the Safety and Tolerability of AC-1101 Topical Gel in Patients with Granuloma Annulare (NCT05580042)TWi Biotechnology, Inc.2022-10-03
Tofacitinib Citrate Topical Gel 3.2% FDA BA Bridging Study (NCT04468425)TWi Biotechnology, Inc.2020-10-14
Prophylactic Treatment of Skin Rash Associated With EGFR Inhibitor Therapy (NCT04239846)TWi Biotechnology, Inc.2019-10-02
A Double-blind, Intra-individual Comparison, POC Trial of AC-203 in EB Patients (NCT03468322)TWi Biotechnology, Inc.2018-10-20
A Proof-of-Concept Study of Topical AC-203 in Patients With Bullous Pemphigoid (NCT03286582)TWi Biotechnology, Inc.2017-09-05

Track TWi Biotechnology, Inc. automatically

Every clearance here is in the API, with alerts when new ones post.